Gilmore Geoffrey Insider Trades

Insider Trading History

Track insider trading activity for Gilmore Geoffrey. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Agile Therapeutics
Agile Therapeutics AGRX
Chief Administrative Officer
Holding Value $15.3k 10,131 shares
Last Trade
Aug 26, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$30.8k 20,256 shares
$1.52
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Administrative Officer
Holding Value $30.6k 20,256 shares
Last Trade
Jun 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.2k 4,500 shares
$2.48
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
Chief Administrative Officer
Holding Value $15.1k 10,000 shares
Last Trade
Nov 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.11M 10,000 shares
$510.75
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $340k 225,000 shares
Last Trade
Jan 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.7B 225,000 shares
$34,200.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $392k 259,740 shares
Last Trade
Jan 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.2B 259,740 shares
$282,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $123k 81,283 shares
Last Trade
Mar 13, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5B 25,500 shares
$196,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $478k 316,667 shares
Last Trade
Jan 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$92.5B 326,738 shares
$283,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $227k 150,000 shares
Last Trade
Jul 03, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.2B 150,000 shares
$148,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $261k 172,600 shares
Last Trade
Jan 29, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.6B 211,100 shares
$83,564.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $69k 45,712 shares
Last Trade
Jan 25, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.49B 17,500 shares
$84,900.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $0 0 shares
Last Trade
Jan 25, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.49B 17,500 shares
$84,900.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $26.4k 17,500 shares
Last Trade
Jan 24, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.46B 16,480 shares
$88,640.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $42.6k 28,212 shares
Last Trade
Jan 24, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.46B 16,480 shares
$88,640.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $227k 150,000 shares
Last Trade
Jun 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.65B 150,000 shares
$57,680.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $51.3k 33,980 shares
Last Trade
Jan 25, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.81B 17,500 shares
$332,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $26.4k 17,500 shares
Last Trade
Jan 25, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.81B 17,500 shares
$332,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $17.7k 11,732 shares
Last Trade
Jan 25, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.91B 5,768 shares
$332,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $162k 107,000 shares
Last Trade
Jan 24, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.7B 123,480 shares
$346,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $211k 140,000 shares
Last Trade
Jan 25, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.6B 175,000 shares
$226,000.00
$1.51
Agile Therapeutics
Agile Therapeutics AGRX
General Counsel
Holding Value $45.3k 30,000 shares
Last Trade
Apr 18, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.4B 30,000 shares
$646,000.00
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up